Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $61.56 USD
Change Today +0.61 / 1.00%
Volume 4.7M
TEVA On Other Exchanges
Symbol
Exchange
New York
OTC US
Mexico
Tel Aviv
Frankfurt
As of 8:04 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - teva pharmaceutical-sp adr (TEVA)

Name (Connections)Board RelationshipsTitleKey Developments
Amir Elstein 42 RelationshipsDirector, Chairman of Corporate Governance & Nominating Committee, Vice Chairman of Finance & Invesment Committee and Member of Audit Committee 
Ory Slonim 12 RelationshipsDirector, Chairman of Corporate Responsibility Committee, Vice Chairman of Corporate Governance & Nominating Committee and Member of Audit Committee 
Joseph Nitzani 12 RelationshipsStatutory Independent Director, Chairman of Audit Committee, Vice Chairman of Human Resources & Compensation Committee, Member of Corporate Governance & Nominating Committee, Member of Finance & Invesment Committee and Member of Corporate Responsibility Committee 
Galia Maor 31 RelationshipsDirector, Chairman of Finance & Invesment Committee, Member of Audit Committee and Member of Corporate Governance & Nominating Committee 
Jean-Michel Halfon 29 RelationshipsDirector, Chairman of Human Resources & Compensation Committee, Vice Chairman of Audit Committee, Vice Chairman of Corporate Responsibility Committee and Member of Science & Technology Committee 

Compensation Committee* - teva pharmaceutical-sp adr (TEVA)

Name (Connections)Board RelationshipsTitle
Roger Abravanel 71 RelationshipsDirector, Member of Finance & Invesment Committee, Member of Human Resources & Compensation Committee and Member of Corporate Governance & Nominating Committee
Jean-Michel Halfon 29 RelationshipsDirector, Chairman of Human Resources & Compensation Committee, Vice Chairman of Audit Committee, Vice Chairman of Corporate Responsibility Committee and Member of Science & Technology Committee
Richard Lerner M.D. 238 RelationshipsDirector, Member of Science & Technology Committee and Member of Human Resources & Compensation Committee
Joseph Nitzani 12 RelationshipsStatutory Independent Director, Chairman of Audit Committee, Vice Chairman of Human Resources & Compensation Committee, Member of Corporate Governance & Nominating Committee, Member of Finance & Invesment Committee and Member of Corporate Responsibility Committee
Key PositionIndustry Range
No Compensation vs Industry data is available for TEVA.
52 Week Price Performance
Share price activity for TEVA PHARMACEUTICAL-SP ADR (TEVA)
TEVA
Industry Average

Nominating Committee* - teva pharmaceutical-sp adr (TEVA)

Name (Connections)Board RelationshipsTitleKey Developments
Amir Elstein 42 RelationshipsDirector, Chairman of Corporate Governance & Nominating Committee, Vice Chairman of Finance & Invesment Committee and Member of Audit CommitteeTeva Pharmaceutical Industries Limited Announces Appointment of Timothy R. Wright as Head of Business Development, Strategy and Innovation
03/23/15
Ory Slonim 12 RelationshipsDirector, Chairman of Corporate Responsibility Committee, Vice Chairman of Corporate Governance & Nominating Committee and Member of Audit CommitteePhillip Frost Resigns from the Board of Directors of Teva Pharmaceutical Industries Ltd
02/5/15
Joseph Nitzani 12 RelationshipsStatutory Independent Director, Chairman of Audit Committee, Vice Chairman of Human Resources & Compensation Committee, Member of Corporate Governance & Nominating Committee, Member of Finance & Invesment Committee and Member of Corporate Responsibility CommitteeTeva Pharmaceutical Industries Ltd. Announces Board Changes, Effective January 1, 2015
11/26/14
Galia Maor 31 RelationshipsDirector, Chairman of Finance & Invesment Committee, Member of Audit Committee and Member of Corporate Governance & Nominating CommitteeTeva Pharmaceutical Industries Limited Announces Board Changes
06/18/14
Roger Abravanel 71 RelationshipsDirector, Member of Finance & Invesment Committee, Member of Human Resources & Compensation Committee and Member of Corporate Governance & Nominating CommitteeTeva Pharmaceutical Industries Limited Announces New Organizational Structure, Effective July 1, 2014; Announces Executive Changes, Effective July 1, 2014
06/2/14

Corporate Governance Committee* - teva pharmaceutical-sp adr (TEVA)

Name (Connections)Board RelationshipsTitle
Roger Abravanel 71 RelationshipsDirector, Member of Finance & Invesment Committee, Member of Human Resources & Compensation Committee and Member of Corporate Governance & Nominating Committee
Amir Elstein 42 RelationshipsDirector, Chairman of Human Resources & Compensation Committee, Vice Chairman of Audit Committee, Vice Chairman of Corporate Responsibility Committee and Member of Science & Technology Committee
Galia Maor 31 RelationshipsDirector, Member of Science & Technology Committee and Member of Human Resources & Compensation Committee
Joseph Nitzani 12 RelationshipsStatutory Independent Director, Chairman of Audit Committee, Vice Chairman of Human Resources & Compensation Committee, Member of Corporate Governance & Nominating Committee, Member of Finance & Invesment Committee and Member of Corporate Responsibility Committee
Ory Slonim 12 Relationships--
TEVA and Competitor
Insiders vs. External
Board
8%
92%
Teva Pharmaceutical Industries Limited
Insiders
External Board Members

Finance Committee* - teva pharmaceutical-sp adr (TEVA)

Name(Connections)Board RelationshipsTitle
Roger Abravanel 71 RelationshipsDirector, Member of Finance & Invesment Committee, Member of Human Resources & Compensation Committee and Member of Corporate Governance & Nominating Committee
Amir Elstein 42 RelationshipsDirector, Chairman of Corporate Governance & Nominating Committee, Vice Chairman of Finance & Invesment Committee and Member of Audit Committee
Galia Maor 31 RelationshipsDirector, Chairman of Finance & Invesment Committee, Member of Audit Committee and Member of Corporate Governance & Nominating Committee
Joseph Nitzani 12 RelationshipsStatutory Independent Director, Chairman of Audit Committee, Vice Chairman of Human Resources & Compensation Committee, Member of Corporate Governance & Nominating Committee, Member of Finance & Invesment Committee and Member of Corporate Responsibility Committee
Erez Vigodman 12 RelationshipsChief Executive Officer, President, Director and Member of Finance & Invesment Committee
Debt To Total Capitalization32.7x
It is important for the finance committee to know when to issue debt or equity.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TEVA:US $61.56 USD +0.61

TEVA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TEVA.
View Industry Companies
 

Industry Analysis

TEVA

Industry Average

Valuation TEVA Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TEVA PHARMACEUTICAL-SP ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.